Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Speak with a qualified healthcare professional and explain exactly what has been used and where it was obtained.
Hepatocyte growth factor promotes cardiac repair after myocardial infarction via c-Met signaling, demonstrating therapeutic potential for heart disease
The trial is closed and completed
This multi-pathway approach is exciting from a therapeutic standpoint its like orchestrating an overall healing response rather than targeting one single receptor
It stimulates the pancreas to release insulin and reduces glucagon, which helps lower blood sugar
PMCID: PMC2129149
US$ 24.41
US$ 21.10
US$ 26.63
US$ 22.83
US$ 25.99
